HealthQuill immune system
Sanofi S.A.’s drug, at its highest dose, has failed to meet its targeted reduction in the yearly rate of worsening episodes in adults with moderate-to-severe asthma, according to a statement.
Drugs Health Pharma

Sanofi’s test drug to treat moderate-to-severe asthma fails to meet goals 

HQ Team April 17, 2025: Sanofi S.A.’s drug, at its highest dose, has failed to meet its targeted reduction in the yearly rate.

Read More
Remember that Covid-19 is still with us, continuously evolving and forming new lineages and we still need to stay ahead of it. Maintaining a cautious vigilance rather than undue panic is the need of the day.
Health Research

COVID-19 increases risk of other infections, study finds

HQ Team April 5, 2025: A recent study reveals that COVID-19 patients face increased risks of other infections for at least a year.

Read More
AstraZeneca’s drug to treat adult patients with previously untreated mantle cell lymphoma has been recommended for European Union approval.
Drugs Health Pharma

AstraZeneca’s mantle cell cancer drug gets body’s nod for EU approval

HQ Team April 1, 2025: AstraZeneca’s drug to treat adult patients with previously untreated mantle cell lymphoma has been recommended for European Union.

Read More
Eli Lilly’s Alzheimer’s experimental drug, donanedab, slowed down cognitive and functional decline in people with early symptoms of the disease, according to a company statement.
Health Research

Key protein ArfGAP2 identified as driver of autoimmune diseases

HQ Team March 20, 2025: Researchers have identified a protein, ArfGAP2, that triggers harmful immune responses in autoimmune diseases, offering a novel target.

Read More
Seventeen types of cancer are common in US millennials and the incidence rate for some forms is two to three times higher in people born in 1990 than in 1995, a study reveals.
Health Research

Aspirin shows promise in preventing cancer metastasis

HQ Team March 10, 2025: University of Cambridge scientists have uncovered the mechanism behind how aspirin could reduce the spread of certain cancers.

Read More
Kisspeptin hormone could treat hypoactive sexual desire disorder when a person has an extremely low sex drive that causes distress, scientists from the Imperial College London and Imperial College Healthcare NHS Trust found.
Health Medical

Guillain Barre Syndrome outbreak in Pune causes one death, 73 affected

HQ Team January 26, 2025: Over 73 people are down with Guillain Barre Syndrome (GBS), a rare nerve disorder, in Pune city in.

Read More
GSK Plc., will invest $800 million in its manufacturing facility in the US — the largest investment to date in the country — to make sterile liquid vaccines and medicines as demand grows.
Drugs Health Pharma

GSK to invest $800 million in US to double capacity at Marietta facility

GSK Plc., will invest $800 million in its manufacturing facility in the US — the largest investment to date in the country — to.

Read More
cancer
Drugs Health Pharma

UK scientists receive funding to develop world’s first ovarian cancer vaccine

HQ Team October 4, 2024: Researchers at the University of Oxford have received £600,000 (€719,960) from Cancer Research UK to fund their project.

Read More
Molecules and microorganisms in the human body dramatically rise or fall at an average age of 44 and 60 affecting both the heart and immune functions, according to a Stanford Medicine study on the biology of ageing.
Drugs Health Pharma

Body undergoes tectonic molecular shifts at age 44, 60: Stanford Medicine

Molecules and microorganisms in the human body dramatically rise or fall at an average age of 44 and 60 affecting both the heart.

Read More
An 82-year-old German male, who took Covid-19 vaccine 217 times, did not have his immune system weakened but rather strengthened, researchers said.
Drugs Health Pharma

German male injects Covid-19 vaccines 217 times, immunity didn’t weaken

HQ Team March 7, 2024: An 82-year-old German male, who took Covid-19 vaccine 217 times, did not have his immune system weakened but.

Read More